Fresenius AG
13
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
88.9%
+2.4% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels
Role: collaborator
Tocilizumab in Chronic Inflammatory CPPD Disease
Role: collaborator
Evaluating the Implementation of Evidence-Based Kidney Nutrition Practice Guidelines: The AUGmeNt Study Protocol
Role: collaborator
Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy
Role: collaborator
Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes
Role: collaborator
T&B Depletion Non Malignant
Role: collaborator
BaSES Trial: Basel Starch Evaluation in Sepsis
Role: collaborator
Parenteral Nutrition Support for Patients With Pancreatic Cancer
Role: collaborator
Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial
Role: collaborator
A Trial of Taurine Supplementation in Parenteral Nutrition 1
Role: collaborator
Hannover Dialysis Outcome Study
Role: collaborator
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
Role: collaborator
The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients
Role: collaborator
All 13 trials loaded